Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_assertion type Assertion NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_head.
- NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_assertion description "[The multidrug-resistance (MR) status of camptothecin (CPT) was investigated in colon adenocarcinoma HT29 cells, leukemia K562, and breast carcinoma MCF7 cells expressing P-glycoprotein (Pgp) and/or MR-associated protein (MRP1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_provenance.
- NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_assertion evidence source_evidence_literature NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_provenance.
- NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_assertion SIO_000772 12115804 NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_provenance.
- NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_assertion wasDerivedFrom befree-20150227 NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_provenance.
- NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_assertion wasGeneratedBy ECO_0000203 NP551624.RA25F3aVA3jC8wWgvMsnzw83rCYS-dR0dTqR27DFAegCk130_provenance.